Processa Pharmaceuticals (PCSA) Interest Coverage Ratio Growth (1y) (2013 - 2025)
Processa Pharmaceuticals (PCSA) Interest Coverage Ratio Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -25.59% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1,170.12% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 751.68% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 99.48% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -53.46% |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -149,674,293.39% |
| Sep 30, 2025 | -2,464.89% |
| Jun 30, 2025 | -244.67% |
| Sep 30, 2024 | -215.55% |
| Jun 30, 2024 | -2,159.50% |
| Mar 31, 2024 | -15.30% |
| Dec 31, 2023 | 84.42% |
| Sep 30, 2023 | 86.56% |
| Jun 30, 2023 | 99.18% |
| Mar 31, 2023 | 97.78% |
| Sep 30, 2022 | -201.73% |
| Jun 30, 2022 | 28.93% |
| Mar 31, 2022 | 43.63% |
| Sep 30, 2021 | -80.58% |
| Jun 30, 2021 | -5,314.84% |
| Mar 31, 2021 | -112,465.55% |
| Dec 31, 2020 | -36.74% |
| Sep 30, 2020 | -1,145.74% |
| Jun 30, 2020 | -2,744.14% |
| Mar 31, 2020 | -11.74% |